Adjuvant nitrate to boost exercise-induced health benefits in older adults - aging-related declines in health and intrinsic capacity are linked to biological processes profoundly affecting all organ…

Active Project Grant Awarded Last action

Award ID
R01AG098800
Recipient
Awarding agency
Obligated
$1,827,526

Award facts

Assistance listing
93.866 Aging Research
Completion date 6% complete
Place of performance
Pensacola, FL 32502, USA

Award details come from USAspending.gov.

About this award

The National Institute on Aging awarded the Florida Institute for Human & Machine Cognition Inc. $1,827,526 on July 15, 2026, under the Aging Research program (CFDA 93.866) to conduct the BOOST-X trial, a randomized controlled study testing whether dietary nitrate supplementation augments the exercise-induced health benefits of combined endurance and resistance training in older adults.

The trial will evaluate nitrate's efficacy in improving cardiorespiratory fitness and functional muscle quality—key markers of degenerative aging linked to vascular endothelial and mitochondrial dysfunction, oxidative stress, and inflammation. Prior work at the recipient institution demonstrated that nitrate and nitrite supplementation in older adults improves physical performance, vascular endothelial function, mitochondrial function, oxidative stress, and muscle inflammation. The study addresses significant inter-individual response heterogeneity to exercise interventions among older adults by testing whether deficits in nitrate bioavailability or exercise-induced nitric oxide production drive suboptimal exercise responsiveness. The trial will be the first to couple a nitrate-rich nutritional supplement with a combined endurance and resistance training prescription aligned with Department of Health and Human Services weekly exercise guidelines.

The award period runs from July 15, 2026, through June 30, 2031. Work is performed in Pensacola, Florida.

Description

Adjuvant nitrate to boost exercise-induced health benefits in older adults - aging-related declines in health and intrinsic capacity are linked to biological processes profoundly affecting all organ systems and tissues including skeletal muscle. Exercise is a multipotent countermeasure to these processes. However, there is significant inter-individual response heterogeneity (IRH) in the magnitude of exercise-induced health benefits. Boosting exercise responsiveness among older adults is thus a top priority. We have found in older adults that supplementation with nitric oxide (no) precursors nitrate and nitrite is safe, well tolerated, and improves: (i) physical performance; (II) vascular endothelial function; (III) mitochondrial function; (IV) oxidative stress; and (v) muscle inflammation. We suspect deficits among some older adults in nitrate bioavailability and/or exercise-induced no production may in part drive suboptimal exercise responsiveness. Given the powerful and sustaining impact of exercise-induced health benefits on morbidity and mortality, our fundamental premise is that exercise responsiveness of every older adult should be maximized. In the boost-x trial we will determine if increasing nitrate bioavailability via dietary supplementation is an efficacious approach to more older adults attaining these essential health benefits. Low cardiorespiratory fitness (CRF, VO2MAX) and low functional muscle quality (FMQ; strength/muscle mass) are multi-system manifestations of degenerative aging that include vascular endothelial and mitochondrial dysfunction, oxidative stress, and inflammation. CRF and FMQ are modifiable with endurance (ET) and resistance (RT) training. This planned trial will be the first to evaluate the efficacy of coupling a nitrate-rich nutritional supplement with a combined ET+RT prescription in line with dhhs weekly exercise guidelines. We will test the central hypothesis that daily nitrate supplementation will augment exercise training-induced gains in CRF and FMQ accompanied by improvements in vascular endothelial and mitochondrial function. Aim 1: assess the clinical impact of nitrate supplementation on the proportion of older adults attaining exercise-induced health benefits. N=226 participants stratified by SEX and age group (60-69 VS ≥70 y) with random assignment to nitrate (400 MG, 2X/day) (n=113) VS. Placebo (nitrate- depleted) (n=113) during 12 WK of 3X/WK ET+RT. 1˚ outcomes: mcid attainment for CRF and FMQ. Expected results: daily nitrate will reduce the proportion of older adults not attaining CRF and FMQ mcids by a full 1/3. Aim 2: assess potential mechanisms underpinning adaptations to exercise +/- nitrate supplementation. We will test/integrate in vivo, EX vivo, in vitro and molecular mapping assays considered central to exercise +/- nitrate adaptations and leverage a multidimensional learning framework to better understand the biocircuitry underpinning mcid attainment. 1˚ outcomes: vascular endothelial function, muscle mitochondrial function. Expected results: mcid attainment will be closely linked to improvements in vascular endothelial function and muscle mitochondrial function. The acute molecular responses to exercise will be differentially regulated by nitrate supplementation, and the novel biocircuitry will reveal key features that influence adaptability.

Quick answers

Who received award R01AG098800?

R01AG098800 was awarded to Florida Institute For Human & Machine Cognition Inc. by National Institute on Aging (National Institutes of Health) on July 15, 2026.

How much is award R01AG098800 worth?

$1,827,526 has been obligated on R01AG098800.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award